ライフサイエンスコーパス: Trypanosoma cruzi

1 ia guyanensis , Leishmania amazonensis , and Trypanosoma cruzi .

2 ureus), a virus (influenza), and a parasite (Trypanosoma cruzi).

3 potentially foodborne parasites (for example Trypanosoma cruzi).

4 y infection caused by the protozoan parasite Trypanosoma cruzi.

5 cal disease caused by the protozoan parasite Trypanosoma cruzi.

6 tes of Leishmania major and epimastigotes of Trypanosoma cruzi.

7 atin America that is caused by the protozoan Trypanosoma cruzi.

8 Rs, are highly susceptible to infection with Trypanosoma cruzi.

9 S) and inflammatory cytokines in response to Trypanosoma cruzi.

10 sed by infection with the protozoan parasite Trypanosoma cruzi.

11 d as a regulator of stage differentiation in Trypanosoma cruzi.

12 has been implemented for West Nile virus and Trypanosoma cruzi.

13 ase is caused by infection with the parasite Trypanosoma cruzi.

14 rucial for control of the protozoan parasite Trypanosoma cruzi.

15 the kinetoplastidea including Leishmania and Trypanosoma cruzi.

16 asitemia and mortality in mice infected with Trypanosoma cruzi.

17 ed from endothelial cells were infected with Trypanosoma cruzi.

18 used by the kinetoplastid protozoan parasite Trypanosoma cruzi.

19 ic analysis of the four life-cycle stages of Trypanosoma cruzi.

20 ic protection against the protozoan pathogen Trypanosoma cruzi.

21 ma brucei, 27 in Leishmania major, and 24 in Trypanosoma cruzi.

22 obe directed at a kinetoplast DNA segment of Trypanosoma cruzi.

23 CI 2.2-6.8) were estimated to be infected by Trypanosoma cruzi.

24 viduals infected with the protozoan parasite Trypanosoma cruzi.

25 mmunity following intradermal infection with Trypanosoma cruzi.

26 ection caused by the intracellular protozoan Trypanosoma cruzi.

27 s' disease, caused by the protozoan parasite Trypanosoma cruzi.

28 the authors present a 2.5-A structure of the Trypanosoma cruzi 60S ribosomal subunit and propose a mo

29 Trypanosoma cruzi, a parasite that causes Chagas' diseas

30 The in vitro and in vivo anti- Trypanosoma cruzi activity of the pyrazole-containing ma

31 ith selective and significant in vitro anti- Trypanosoma cruzi activity.

32 re than 20 outstanding derivatives with anti-Trypanosoma cruzi activity.

33 Chagas disease is caused by the protozoan Trypanosoma cruzi, affecting millions of people worldwid

34 as disease, caused by the protozoan parasite Trypanosoma cruzi, affects 7 million people in Latin Ame

35 ease, caused by the hemoflagellate protozoan Trypanosoma cruzi, affects millions of people in South a

36 gas disease is a chronic infection caused by Trypanosoma cruzi, an intracellular protozoan parasite.

37 disease is caused by the protozoan parasite Trypanosoma cruzi and affects 5-8 million people in Lati

38 in the infective and intracellular stages of Trypanosoma cruzi and are recognized as antigenic target

39 Chagas disease is caused by the parasite Trypanosoma cruzi and is an important cause of morbidity

40 ago, is caused by the intracellular parasite Trypanosoma cruzi and is most frequently associated with

41 f Kinetoplastida -Trypanosoma brucei brucei, Trypanosoma cruzi and Leishmania major - are now complet

42 s of the human parasites Trypanosoma brucei, Trypanosoma cruzi and Leishmania major.

43 rasite genome sequences: Trypanosoma brucei, Trypanosoma cruzi and Leishmania major.

44 lular protozoan parasites Toxoplasma gondii, Trypanosoma cruzi and Leishmania spp. target macrophages

45 have been considered as virulence factors of Trypanosoma cruzi and Leishmania spp., and have been dem

46 interactions between the protozoan parasite Trypanosoma cruzi and mammalian hosts at primary sites o

47 e is a chronic infection in humans caused by Trypanosoma cruzi and manifested in progressive cardiomy

48 rified Complex II from the parasitic protist Trypanosoma cruzi and obtained the unexpected result tha

49 mans: Toxoplasma gondii, Trypanosoma brucei, Trypanosoma cruzi and Plasmodium falciparum.

50 Entamoeba histolytica, Leishmania spp., Trypanosoma cruzi and Trichomonas vaginalis have genes e

51 Trypanosoma cruzi and Trypanosoma brucei are parasites t

52 to human disease, i.e. Leishmania donovani, Trypanosoma cruzi and Trypanosoma brucei.

53 ng the etiological agents of Chagas disease (Trypanosoma cruzi) and African sleeping sickness (Trypan

54 disease is caused by the protozoan parasite Trypanosoma cruzi, and activation of CD8(+) T cells is c

55 in the developing world, rheumatic carditis, Trypanosoma cruzi, and bacterial infections such as diph

56 strate binding cavities (Trypanosoma brucei, Trypanosoma cruzi, and L. infantum) suggests that substr

57 d pathogens (Trypanosoma brucei rhodesiense, Trypanosoma cruzi, and Leishmania donovani), and several

58 d pathogens (Trypanosoma brucei rhodesiense, Trypanosoma cruzi, and Leishmania donovani), and two com

59 equence of the pathogens Trypanosoma brucei, Trypanosoma cruzi, and Leishmania major provides an oppo

60 logues in the genomes of Trypanosoma brucei, Trypanosoma cruzi, and Leishmania major were identified.

61 d genome architecture of Trypanosoma brucei, Trypanosoma cruzi, and Leishmania major, three related p

62 infections due to Toxoplasma gondii (n = 3), Trypanosoma cruzi, and Leishmania species.

63 the protozoan parasites Trypanosoma brucei, Trypanosoma cruzi, and Leishmania spp.

64 cellular human parasites Trypanosoma brucei, Trypanosoma cruzi, and Leishmania spp., the spliced-lead

65 lude the human pathogens Trypanosoma brucei, Trypanosoma cruzi, and Leishmania spp., which in humans

66 of the trypanosomatids: Trypanosoma brucei, Trypanosoma cruzi, and Leishmania.

67 asitic pathogens including Leishmania major, Trypanosoma cruzi, and Neisseria gonorrhoeae.

68 mes have been studied in Trypanosoma brucei, Trypanosoma cruzi, and various Leishmania species.

69 ther eukaryotes, the protein-coding genes of Trypanosoma cruzi are arranged in large polycistronic ge

70 Brucella spp. and Trypanosoma cruzi are two intracellular pathogens that h

71 igotes, the highly motile infective forms of Trypanosoma cruzi, are capable of infecting several cell

72 ng infection with the intracellular parasite Trypanosoma cruzi, as evidenced by transcriptome and cyt

73 The Trypanosoma cruzi ascorbate peroxidase is, by sequence a

74 protein (FCaBP) of the flagellated protozoan Trypanosoma cruzi associates with the flagellar membrane

75 Several compounds that kill Trypanosoma cruzi at subnanomolar concentrations and are

76 NF) produced by the Chagas' disease parasite Trypanosoma cruzi binds nerve growth factor (NGF) recept

77 bolically challenged and upon infection with Trypanosoma cruzi (Brazil strain) suffer high mortality.

78 linical trials, was previously found to kill Trypanosoma cruzi by blocking sterol 14 alpha-demethylas

79 tually enhances infection with the protozoan Trypanosoma cruzi, by a mechanism that may involve facil

80 kills the causative agent of Chagas disease, Trypanosoma cruzi, by blocking ergosterol biosynthesis a

81 ole and posaconazole have not been tested in Trypanosoma cruzi carriers.

82 Trypanosoma cruzi causes American trypanosomiasis, where

83 Trypanosoma cruzi causes Chagas disease (American trypan

84 examined the Leishmania major (Friedlin) and Trypanosoma cruzi (CL Brener) genome projects for SL RNA

85 The Chagas' disease parasite Trypanosoma cruzi commonly infects humans through skin a

86 mania species, unlike Trypanosoma brucei and Trypanosoma cruzi, contain genes encoding MTHFR and two

87 aminopyridyl-based lead inhibitors targeting Trypanosoma cruzi CYP51 (TcCYP51) has been developed usi

88 Activation of innate immune cells by Trypanosoma cruzi-derived molecules such as GPI anchors

89 rom the parasite that causes Chagas disease, Trypanosoma cruzi, directly in whole, unprocessed human

90 he pathogenic species Trypanosoma brucei and Trypanosoma cruzi, edit their post-transcriptional mitoc

91 Loss of a single copy of this gene in Trypanosoma cruzi, either through in vitro drug selectio

92 The Chagas' disease parasite Trypanosoma cruzi elicits a potent inflammatory response

93 ovel finding that the intracellular pathogen Trypanosoma cruzi elicits immediate and sustained repres

94 The genome of the parasite Trypanosoma cruzi encodes two copies of autophagy-relate

95 by the oligosaccharyltransferase (OST) from Trypanosoma cruzi, Entamoeba histolytica, Trichomonas va

96 n, purification, and characterization of the Trypanosoma cruzi exopolyphosphatase (TcPPX).

97 The protozoan Trypanosoma cruzi expresses multiple isoforms of the GP6

98 PDNF, produced by the Chagas' disease agent Trypanosoma cruzi, functionally mimics mammalian neurotr

99 s a putative nucleoside phosphorylase in the Trypanosoma cruzi genome was overexpressed in Escherichi

100 is shown to be a highly potent inhibitor of Trypanosoma cruzi growth (ED(50) = 4 nM).

101 e extreme genetic diversity of the protozoan Trypanosoma cruzi has been proposed to be associated wit

102 The protozoan parasite Trypanosoma cruzi has evolved sophisticated systems to e

103 The protist parasite Trypanosoma cruzi has evolved the ability to transit bet

104 Oral transmission of Trypanosoma cruzi has gained relevance because of its as

105 Recent discussions on the evolution of Trypanosoma cruzi have been dominated by the southern su

106 nosoma brucei, and the American trypanosome, Trypanosoma cruzi, have the capacity to synthesize vitam

107 Finally, we show that the Trypanosoma cruzi homologue of PrpA also targets macroph

108 presumably by keeping the etiological agent Trypanosoma cruzi in check through protective immunity a

109 The journey of the Chagas' disease parasite Trypanosoma cruzi in the human body usually starts in th

110 Trypanosoma cruzi-induced inflammatory pathology and a f

111 Infection with Trypanosoma cruzi induces inflammation, which limits par

112 ar why only a proportion of children born to Trypanosoma cruzi-infected mothers acquire the infection

113 ivities (39 to 58%) and ATP (38%) content in Trypanosoma cruzi-infected murine hearts compared with n

114 of Chagas cardiomyopathy among asymptomatic Trypanosoma cruzi-infected persons.

115 ongenital transmission and cardiomyopathy in Trypanosoma cruzi-infected women.

116 patients with suspected or confirmed chronic Trypanosoma cruzi infection (Chagas disease).

117 Trypanosoma cruzi infection (which causes Chagas disease

118 Diagnostic methods for detecting Trypanosoma cruzi infection are important to allow admin

119 nic epithelial model HCT116 cells respond to Trypanosoma cruzi infection by secreting defensin alpha-

120 Trypanosoma cruzi infection causes cardiomyopathy and va

121 Trypanosoma cruzi infection causes cardiomyopathy and va

122 The innate immune response to Trypanosoma cruzi infection comprises several pattern re

123 at immune responses in subjects with chronic Trypanosoma cruzi infection display features common to o

124 Trypanosoma cruzi infection drives the expansion of rema

125 Increasingly during the past few decades, Trypanosoma cruzi infection has been detected in North A

126 mmunochromatographic dipstick test to detect Trypanosoma cruzi infection in 366 human serum samples w

127 or T-bet (Tbx21) regulates Th17 responses to Trypanosoma cruzi infection in an IFN-gamma-independent

128 We studied Trypanosoma cruzi infection in mice in which NRF2/HO-1 w

129 e required for host control of intracellular Trypanosoma cruzi infection in mice, although the basis

130 city and equivalent or improved efficacy for Trypanosoma cruzi infection is a priority.

131 Trypanosoma cruzi infection leads to development of a ch

132 loss of certain functional activities during Trypanosoma cruzi infection might result in the inabilit

133 to reach cardiac tissue in vivo, even after Trypanosoma cruzi infection, a known inducer of lymphoid

134 ion of Th17 cells, we used a murine model of Trypanosoma cruzi infection, a protozoan parasite that c

135 Here, we report that during Trypanosoma cruzi infection, interleukin-12 (IL-12) defi

136 nic Chagas disease cardiomyopathy, caused by Trypanosoma cruzi infection, is a major cause of heart f

137 Using a model of Trypanosoma cruzi infection, we demonstrate that in cont

138 tablishing a system for drug cure of chronic Trypanosoma cruzi infection, we present the first extens

139 Trypanosoma cruzi infection, which is the etiological ag

140 e tissue (WAT) and adipocytes are targets of Trypanosoma cruzi infection.

141 CD8(+) T cells are essential for controlling Trypanosoma cruzi infection.

142 o be relevant in the context of experimental Trypanosoma cruzi infection.

143 eviously described in immune response during Trypanosoma cruzi infection.

144 ine protease cruzipain (Cz) protects against Trypanosoma cruzi infection.

145 uestions in detail using the murine model of Trypanosoma cruzi infection.

146 afety of benznidazole in adults with chronic Trypanosoma cruzi infection.

147 es to lymphocytic choriomeningitis virus and Trypanosoma cruzi infections, and a specific defect in C

148 In chronic Trypanosoma cruzi infections, parasite burden is control

149 Trypanosoma cruzi infects 15 to 20 million people in Lat

150 Trypanosoma cruzi infects millions of people in Latin Am

151 oles) displayed significant activity against Trypanosoma cruzi intracellular amastigotes (IC(50) rang

152 sly implicated in plasma membrane repair and Trypanosoma cruzi invasion, events which are mediated by

153 Infection with the protozoan parasite Trypanosoma cruzi is a major cause of morbidity and mort

154 Chagas disease caused by Trypanosoma cruzi is a paradigmatic example of a chronic

155 Trypanosoma cruzi is a protozoan parasite that can initi

156 Trypanosoma cruzi is a protozoan parasite that causes hu

157 Trypanosoma cruzi is an intracellular parasite and the c

158 Trypanosoma cruzi is an intracellular protozoan parasite

159 om basic amino acids, the protozoan parasite Trypanosoma cruzi is incapable of polyamine biosynthesis

160 Genetic variation in Trypanosoma cruzi is likely a key determinant in transmi

161 flagellar calcium-binding protein (FCaBP) of Trypanosoma cruzi is localized to the flagellar membrane

162 ium-binding protein (FCaBP) of the protozoan Trypanosoma cruzi is targeted to the flagellar membrane

163 The parasitic protozoan organism Trypanosoma cruzi is the causative agent of Chagas disea

164 The insect-transmitted protozoan parasite Trypanosoma cruzi is the causative agent of Chagas disea

165 Trypanosoma cruzi is the causative agent of chronic chag

166 Trypanosoma cruzi is the etiologic agent of Chagas disea

167 Trypanosoma cruzi is the etiologic agent of Chagas' dise

168 Trypanosoma cruzi is the etiological agent of Chagas dis

169 Trypanosoma cruzi is the protozoan parasite that causes

170 Trypanosoma cruzi is wrapped by a dense coat of mucin-ty

171 sed by infection with the protozoan parasite Trypanosoma cruzi, is a leading cause of heart disease (

172 Chagas disease, caused by the parasite Trypanosoma cruzi, is a serious health problem in Latin

173 aused by the eukaryotic (protozoan) parasite Trypanosoma cruzi, is an alarming emerging global health

174 Chagas disease, caused by Trypanosoma cruzi, is an important cause of morbidity an

175 Chagas disease, caused by the protozoan Trypanosoma cruzi, is endemic in Latin America and affec

176 Chagas disease, caused by the parasite Trypanosoma cruzi, is endemic in Latin America.

177 me found in parasitic Leishmania species and Trypanosoma cruzi, is implicated in deglutathionylation

178 l of many intracellular pathogens, including Trypanosoma cruzi, is reported to be dependent on the pr

179 s' disease, caused by the protozoan parasite Trypanosoma cruzi, is the most common cause of cardiac-r

180 heart disease (CHD), caused by the parasite Trypanosoma cruzi, is the most common form of myocarditi

181 are highly conserved in clinically relevant Trypanosoma cruzi isolates and are recognized by B and T

182 umber of dialkyl imidazoles as inhibitors of Trypanosoma cruzi lanosterol-14alpha-demethylase (L14DM)

183 of intracellular infection by the protozoan Trypanosoma cruzi leads to the development of human Chag

184 parasites: Trypanosoma brucei rhodesiense , Trypanosoma cruzi , Leishmania donovani , and P. falcipa

185 y infection with the kinetoplastid parasites Trypanosoma cruzi, Leishmania spp. and Trypanosoma bruce

186 cellular effects at different stages of the Trypanosoma cruzi life cycle, the structural data provid

187 or Chagas' disease, we evaluated against all Trypanosoma cruzi life stages the in vitro trypanocidal

188 hmania-like flagellum attachment zone, and a Trypanosoma cruzi-like cytostome are ancestral features,

189 a novel mechanism used by diverse pathogens (Trypanosoma cruzi, Listeria monocytogenes, and adenoviru

190 Intracellular parasites like Trypanosoma cruzi may also provide new insights into ove

191 ence for a novel immune evasion mechanism of Trypanosoma cruzi, mediated by host cell plasma membrane

192 During experimental infection with Trypanosoma cruzi, mice develop a strong CD8(+) T cell r

193 896 patients; 60.5% had positive results for Trypanosoma cruzi on PCR.

194 no significant activity was detected against Trypanosoma cruzi or Leishmania donovani.

195 rom MIIG mice were unable produce NO or kill Trypanosoma cruzi or Leishmania major after priming with

196 This approach also revealed that the Trypanosoma cruzi ortholog (TcSLS1) is a dedicated inosi

197 A century after discovering that the Trypanosoma cruzi parasite is the etiological agent of C

198 Chagas disease, caused by Trypanosoma cruzi parasite, was described thousands of y

199 Trypanosoma cruzi parasites are the causative agents of

200 mice with the myotropic Colombiana strain of Trypanosoma cruzi, parasites persisted in tissue at low

201 the structures of Leishmania major PDEB1 and Trypanosoma cruzi PDEC.

202 and virulence of Trypanosoma brucei and, in Trypanosoma cruzi, PDEC2 was shown to be required for no

203 Trypanosoma cruzi phosphodiesterase C (TcrPDEC) is a pot

204 A unique Trypanosoma cruzi PI-PLC (TcPI-PLC) is lipid modified in

205 A newly discovered Trypanosoma cruzi PI-PLC (TcPI-PLC) is lipid modified in

206 A unique Trypanosoma cruzi PI-PLC (TcPI-PLC) is lipid-modified in

207 ro against T rypanosoma brucei rhodesiense , Trypanosoma cruzi , Plasmodium falciparum , and Leishman

208 e parasite sources of these three proteases, Trypanosoma cruzi, Plasmodium falciparum, and Trypanosom

209 ork was to analyze the predictive value of a Trypanosoma cruzi-positive polymerase chain reaction (PC

210 EbS was more toxic for T. brucei than for Trypanosoma cruzi, probably due to lower levels of TryR

211 e infectious stage of the protozoan parasite Trypanosoma cruzi produces a surface-anchored complement

212 eukaryotic parasites Trypanosoma brucei and Trypanosoma cruzi provide a first structural view of a e

213 AdoMetDC from the protozoal parasite Trypanosoma cruzi requires putrescine for maximal enzyme

214 Immune control of the protozoan parasite Trypanosoma cruzi requires the activation of both CD4+ a

215 uM against neglected Chagas' disease causing Trypanosoma cruzi, respectively.

216 Infection with the protozoan parasite Trypanosoma cruzi results in a robust and multifaceted i

217 sceptible mice with the Colombiana strain of Trypanosoma cruzi results in an orchestrated expression

218 -genome sequencing of the protozoan pathogen Trypanosoma cruzi revealed that the diploid genome conta

219 comparison of the dUTPases from C.jejuni and Trypanosoma cruzi reveals a common fold with certain dis

220 es, we determined the 2.5-A structure of the Trypanosoma cruzi ribosome large subunit by single-parti

221 Experimental animals infected by Trypanosoma cruzi showed an early rise in myocardial and

222 Trypanosoma cruzi species is categorized into six discre

223 in the activation and functional profile of Trypanosoma cruzi-specific DN T cells.

224 rystal structures of the drug target enzyme, Trypanosoma cruzi sterol 14alpha-demethylase (CYP51), co

225 Sialoglycoprotein from Trypanosoma cruzi strains participates in important biol

226 expressed in the heart after infection with Trypanosoma cruzi, suggesting that they play an importan

227 The mechanisms by which Trypanosoma cruzi survives antimicrobial peptides and di

228 c fungicide fenarimol (1) as an inhibitor of Trypanosoma cruzi ( T. cruzi ), the causative agent of C

229 Trypanosoma cruzi (T. cruzi) infection is endemic in Lat

230 as disease, caused by the protozoan parasite Trypanosoma cruzi (T. cruzi), is an increasing threat to

231 hibited the growth of the parasitic protozoa Trypanosoma cruzi, T. brucei, and Leishmania donovani.

232 Trypanosoma cruzi (TC) causes Chagas disease, which in i

233 om the enzymes of Homo sapiens (Hs-SAHH) and Trypanosoma cruzi (Tc-SAHH) are qualitatively similar bu

234 Homo sapiens (Hs-SAHH) and from the parasite Trypanosoma cruzi (Tc-SAHH) are very similar in structur

235 We cloned an aquaporin gene from Trypanosoma cruzi (TcAQP) that encodes a protein of 231

236 hibitors of the carbonic anhydrase (CA) from Trypanosoma cruzi (TcCA).

237 gas disease, sterol 14alpha-demethylase from Trypanosoma cruzi (TCCYP51), was found to be catalytical

238 bound to a distinctive Argonaute protein of Trypanosoma cruzi, TcPIWI-tryp.

239 vector-borne pathogens, with the example of Trypanosoma cruzi (the etiological agent of Chagas disea

240 re effective agents against proliferation of Trypanosoma cruzi , the etiologic agent of American tryp

241 Trypanosoma cruzi, the agent of Chagas disease, does not

242 The human parasite Trypanosoma cruzi, the agent of Chagas' disease, express

243 Trypanosoma cruzi, the agent of Chagas' disease, infects

244 Trypanosoma cruzi, the agent of Chagas' disease, promote

245 f a number of protozoan pathogens, including Trypanosoma cruzi, the agent of human Chagas disease.

246 Using a murine model of infection with Trypanosoma cruzi, the causal agent of Chagas cardiomyop

247 lled intestinal microbiota, neither affected Trypanosoma cruzi, the causal agent of Chagas disease, i

248 Trypanosoma cruzi, the causative agent of Chagas disease

249 characterized from the unicellular protozoan Trypanosoma cruzi, the causative agent of Chagas disease

250 the major cysteine protease of the protozoan Trypanosoma cruzi, the causative agent of Chagas disease

251 znidazole is the frontline drug used against Trypanosoma cruzi, the causative agent of Chagas disease

252 The release of EVs by Trypanosoma cruzi, the causative agent of Chagas disease

253 ted with AT during part of their life cycle: Trypanosoma cruzi, the causative agent of Chagas disease

254 and biochemical features of telomerase from Trypanosoma cruzi, the causative agent of Chagas disease

255 Trypanosoma cruzi, the causative agent of Chagas disease

256 gi, and more recently the protozoan parasite Trypanosoma cruzi, the causative agent of Chagas disease

257 st resistance to the intracellular protozoan Trypanosoma cruzi, the causative agent of Chagas' diseas

258 trans-Sialidase is an essential enzyme for Trypanosoma cruzi, the causative agent of Chagas' diseas

259 However, the extent of the repeats within Trypanosoma cruzi, the causative agent of Chagas' diseas

260 alpha-1 displays a trypanocidal role against Trypanosoma cruzi, the causative agent of Chagas' diseas

261 casein kinase II (CKII) substrate (Tc-1) of Trypanosoma cruzi, the causative agent of Chagas' diseas

262 (NMT), an essential and druggable target in Trypanosoma cruzi, the causative agent of Chagas' diseas

263 Trypanosoma cruzi, the causing agent of Chagas disease,

264 Trypanosoma cruzi, the etiologic agent of Chagas disease

265 Methods for genetic manipulation of Trypanosoma cruzi, the etiologic agent of Chagas disease

266 of the contractile vacuole complex (CVC) of Trypanosoma cruzi, the etiologic agent of Chagas disease

267 Trypanosoma cruzi, the etiological agent of Chagas disea

268 A consensus is now emerging that Trypanosoma cruzi, the etiological agent of Chagas disea

269 critical events throughout the life cycle of Trypanosoma cruzi, the etiological agent of Chagas disea

270 ed to date including heteroxenous members of Trypanosoma cruzi, the extracellular Trypanosoma brucei,

271 Trypanosoma cruzi, the intracellular protozoan parasite

272 n, of the structure of the 80S ribosome from Trypanosoma cruzi, the kinetoplastid protozoan pathogen

273 ves that inhibit TIM's catalytic activity in Trypanosoma cruzi, the parasite that causes Chagas disea

274 During invasion of host cells by Trypanosoma cruzi, the parasite that causes Chagas disea

275 Trypanosoma cruzi, the protozoan parasite that causes hu

276 It is thought that Trypanosoma cruzi, the protozoan that causes Chagas' dis

277 idate clathrin-associated proteins (CAPs) in Trypanosoma cruzi; the cohort includes orthologs of many

278 Cryptosporidium parvum, Leishmania spp., Trypanosoma cruzi, Theileria spp., Toxoplasma gondii and

279 elivers Gzms into three protozoan parasites (Trypanosoma cruzi, Toxoplasma gondii and Leishmania majo

280 othione and analogues (2-4) as inhibitors of Trypanosoma cruzi TR.

281 Trypanosoma cruzi trans-sialidase (TcTS) is a key target

282 The Trypanosoma cruzi trans-sialidase (TS) is a unique enzym

283 Congenital Trypanosoma cruzi transmission is now estimated to accou

284 The intracellular protozoan parasite Trypanosoma cruzi triggers a robust type I IFN response

285 on host cell contact, the protozoan parasite Trypanosoma cruzi triggers cytosolic Ca(2+) transients t

286 ors in the L. major, Trypanosoma brucei, and Trypanosoma cruzi (Tritryp) genomes suggest that the mec

287 tandem-repeated genes display codon bias in Trypanosoma cruzi, Trypanosoma brucei and Leishmania maj

288 Human galectin-3 binds to the surface of Trypanosoma cruzi trypomastigotes and human coronary art

289 pest insect that has the ability to transmit Trypanosoma cruzi under experimental laboratory conditio

290 The transition state for the Trypanosoma cruzi uridine phosphorylase (TcUP) reaction

291 sceptible mice with the Colombiana strain of Trypanosoma cruzi was characterized in an attempt to det

292 Serological testing for Trypanosoma cruzi was performed at enrollment.

293 telomeres in the South American Trypanosome, Trypanosoma cruzi, we became interested in the telomeric

294 The parasite Trypanosoma cruzi which is transmitted by triatomine bug

295 es that the intracellular protozoan parasite Trypanosoma cruzi, which causes heart disease in chronic

296 disease is caused by the protozoan parasite Trypanosoma cruzi, which depends on the production of en

297 Here, using the protozoan parasite Trypanosoma cruzi, which is deficient in strong PAMPs, w

298 Cruzain is the major cysteine protease of Trypanosoma cruzi, which is the causative agent of Chaga

299 m falciparum, Trypanosoma brucei brucei, and Trypanosoma cruzi will be outlined.

300 oride inhibited trypanothione reductase from Trypanosoma cruzi with a linear competitive Ki value of